United Kingdom

People: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

14 Jun 2019
Change (% chg)

¥30 (+0.48%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kobayashi, Hiroyuki 

Mr. Hiroyuki Kobayashi has been serving as Executive Officer, Chief Medical Officer of Japan & Asia and Chief Director of Medical in Eisai Co., Ltd. since June 2017. He joined the Company in January 2016. His previous titles include Director of Neurology Medical Department and Director of Oncology Medical in the Company. He used to work for Otsuka Pharmaceutical Co., Ltd.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --